[Cryotherapy for prostate cancer].
BACKGROUND
The paper describes the principles and technique of cryotherapy for prostate cancer.


METHODS
From September 2003 to January 2005 we have treated 40 patients with localised prostate cancer. Among patients with T1-2 tumours, Gleason score < 7 and PSA < 10 ng/ml, average prostate-specific antigen (PSA) after 3 months is 0.32 (< 0.05-1.2) ng/ml. Among patients with T1-2, Gleason score > or = 7 or PSA > or = 10, average PSA after 3 months is 0.56 (< 0.05-1.9) ng/ml.


CONCLUSIONS
Two patients needed intermittent catheterisation for a short period and underwent revision of the prostatic cavity. After 3 months, however, all patients had normal micturition. The prostate was not palpable in any of the patients. Our experience is encouraging and comparable to what has recently been reported from other countries.
Urologisk seksjon, Sykehuset Telemark, 3901 Porsgrunn. tebj@sthf.no
Truls E Bjerklund
TE
Johansen
D000368:Aged; D017679:Cryotherapy / Q000295:instrumentation / Q000379:methods; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy*; D016896:Treatment Outcome; D014463:Ultrasonography